18F-FDG PET/CT influences management in patients with known or suspected pancreatic cancer
- 11 May 2010
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 41 (11) , 776-783
Abstract
The aims of this study were (i) to assess and validate the incremental information of positron emission tomography/computed tomography (PET/CT) over conventional staging investigations (CSI) and (ii) to assess the management impact of PET/CT in patients with known or suspected pancreatic cancer. Between October 2007 and September 2008, 22 PET/CT scans were performed using a dedicated PET/CT scanner in 21 patients with known or suspected pancreatic cancer. Follow up was used to reconcile discordance between PET/CT and CSI. The pre-PET/CT management plan and/or intent were prospectively recorded in all scans. The post-PET/CT management plan was determined from the medical record and/or discussions with treating clinicians. The management impact of PET/CT was classified as high, medium, low or none defined using Australian and New Zealand Association of Physicians in Nuclear Medicine PET data collection project criteria. PET/CT and CSI were discordant in 14/22 (64%: 95% CI; 43-84%) scans. Of the 14 discordant scans, PET/CT assessment was correct in eight, conventional imaging in four and there was insufficient information in two. Overall, PET/CT management impact was classified as high (n= 6), medium (n= 3), low (n= 9) or none (n= 4). Significant changes in management (high or medium impact) were induced by PET/CT in 9/22 scans (41%: 95% CI; 20-62%) predominantly by correctly modifying the disease extent. PET/CT has an incremental benefit over CSI and has a significant impact on management in patients with known or suspected pancreatic cancer. PET/CT merits consideration as part of the non-invasive evaluation of patients with known or suspected pancreatic cancer.Keywords
This publication has 17 references indexed in Scilit:
- Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET RegistryJournal of Nuclear Medicine, 2008
- PET/CT Fusion Scan Enhances CT Staging in Patients with Pancreatic NeoplasmsAnnals of Surgical Oncology, 2008
- Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinomaSurgery, 2007
- Positron Emission Tomography/Computed Tomography Influences on the Management of Resectable Pancreatic Cancer and Its Cost-EffectivenessAnnals of Surgery, 2005
- Surgery for Pancreatic Cancer: Recent Controversies and Current PracticeGastroenterology, 2005
- F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective studyJournal of Gastrointestinal Surgery, 2005
- Pancreatic cancerThe Lancet, 2004
- Role of dual PET/CT scanning in abdominal malignanciesCancer Imaging, 2004
- Diagnostic usefulness of FDG PET for pancreatic mass lesionsAnnals of Nuclear Medicine, 2001
- 18Fluorodeoxyglucose-Positron Emission Tomography in the Management of Patients With Suspected Pancreatic CancerAnnals of Surgery, 1999